Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Ceapro Inc
V.CZO
Chemicals
Specialty Chemicals
Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human...
, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:CZO)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Mar 15, 2024 9:43am
Bids
2019 lots bid on NASDAQ for AEZS. 1484 lots or 742,000 shares bid on the TSX-V for CZO.
(12)
•••
ZoranSto
X
View Profile
View Bullboard History
Comment by
ZoranSto
on Mar 15, 2024 9:37am
RE:RE:RE:RE:732,000 share bid at $.23
Yep still there.....so far on the open NO takers....could be interesting
Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million
posted Nov 21, 2024 9:00am by
Innocan Pharma Corp
-
|
"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Mar 15, 2024 9:17am
RE:RE:RE:732,000 share bid at $.23
The bid is still there as of the moment. It effectively calls the bluff of the bashers as they refuse to sell into it despite chronic whining concerning a lack of liquidity and their fear about a risk
...more
(12)
•••
ZoranSto
X
View Profile
View Bullboard History
Comment by
ZoranSto
on Mar 15, 2024 8:37am
RE:RE:732,000 share bid at $.23
That is a very large bid....I wonder if it will remain today....lets wait and see.
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Mar 15, 2024 5:41am
AIM Biologicals
AEZS has said that its most exciting pipeline program is probably AIM Biologicals. The lead product candidate alone targets a US$2.5 billion market. What could this program be worth if successfully
...more
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Mar 14, 2024 4:10pm
RE:732,000 share bid at $.23
And the 732,000 share bid just sat there. Why didn't it get hit by a single share? Post by boazklinghornon Mar 11, 2024 9:49am 113 Views Post# 35926132
...more
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Mar 14, 2024 3:13pm
732,000 share bid at $.23
Biggest bid I can ever remember.
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Mar 14, 2024 12:50pm
RE:RE:S&P Biotech ETF
US headline inflation bottomed 8 months ago above the US Federal Reserves target...
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Mar 14, 2024 12:39pm
RE:S&P Biotech ETF
As markets worry about higher inflation the toll of inflation and interest rate hikes may finally be hitting the consumer. How much does Aveeno and Neutrogena, etc.
...more
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Mar 14, 2024 11:57am
S&P Biotech ETF
S&P Biotech ETF is suddenly down about 9% from its high within the last month. Did Gilles manage to secure cash with the merger ahead of a potential inflation scare that could crush biotech stocks
...more
(2012)
•••
Ciao
X
View Profile
View Bullboard History
Comment by
Ciao
on Mar 14, 2024 8:59am
RE:RE:New Press Release - Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings
If you add the current market cap of both AEZS and CZO you will get about $30M CDN in total. Divide that by the 15M shares and you will end up with a share price of about $2 CDN / share. If the market
...more
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Mar 14, 2024 5:22am
Given the key events expected in the next month or so...
What happens if an analyst like H.C. Wainwright writes up the new story for the first time? Does H.C. Wainwright's US$15 AEZS target suddenly look more realizable to the market?
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Mar 13, 2024 1:54pm
May 6, 2021 on AEZS's AIM Biologicals
Aeterna Buys Promising Targeted Immunosuppressive Therapy Platform by Marta Figueiredo, PhD | May 6, 2021
...more
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Mar 13, 2024 8:39am
RE:RE:Now that we’re all AEZS shareholders
With the completion of AEZS's diagnostic clinical trial the costs for the clinical trial for the test falls off. They can streamline human infrastructure as only one CEO, CFO, VP Business
...more
(19)
•••
scarface9
X
View Profile
View Bullboard History
Comment by
scarface9
on Mar 13, 2024 8:28am
RE:Now that we’re all AEZS shareholders
Will there be a restructuring and lay offs at head office. Only one CEO, CFO needed now, so somebody has to go. Plus a lot of other positions will now be redundant and can be consolidated.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover Options Trading Strategies to Minimize your Tax Burden